购物车
- 全部删除
- 您的购物车当前为空
Anti-Siglec-2/CD22 Antibody (4W529) 是一种 Rabbit 抗体,靶向 Siglec-2/CD22。Anti-Siglec-2/CD22 Antibody (4W529) 可用于 WB,IP。
Anti-Siglec-2/CD22 Antibody (4W529) 是一种 Rabbit 抗体,靶向 Siglec-2/CD22。Anti-Siglec-2/CD22 Antibody (4W529) 可用于 WB,IP。
产品描述 | Anti-Siglec-2/CD22 Antibody (4W529) is a Rabbit antibody targeting Siglec-2/CD22. Anti-Siglec-2/CD22 Antibody (4W529) can be used in WB,IP. |
Ig Type | Monoclonal Rabbit IgG |
克隆号 | 4W529 |
交叉反应 | Mouse |
验证活性 | 1. Anti-CD22 rabbit monoclonal antibody at 1:500 dilution. -Lane A: Raji Whole Cell lysate. -Lysates/proteins at 30 μg per lane. -Secondary -Goat Anti-Rabbit IgG H&L (Dylight800) at 1/10000 dilution. -Developed using the Odyssey technique. -Performed under reducing conditions. -Predicted band size:95 kDa. -Observed band size:150 kDa. 2. Mouse CD22 was immunoprecipitated using: -Lane A:0.5 mg 293T Whole Cell Lysate. -2 µL anti-Mouse CD22 rabbit monoclonal antibody and 60 μg of Immunomagnetic beads Protein G. -Primary antibody: -Anti-Mouse CD22 rabbit monoclonal antibody, at 1:100 dilution. -Secondary antibody: -Dylight 800-labeled antibody to rabbit IgG (H+L), at 1:5000 dilution. -Developed using the odyssey technique. -Performed under reducing conditions. -Predicted band size: 150 kDa. -Observed band size: 150 kDa |
应用 | WB,IP |
推荐剂量 | WB: 1:500-1:2000; IP: 0.5-2 μL/mg of lysate |
抗体种类 | Monoclonal |
宿主来源 | Rabbit |
构建方式 | This antibody was obtained from a rabbit immunized with purified, recombinant Mouse CD22 (rM CD22; TMPY-04083; BAE33829.1; Met1-Arg708). |
纯化方式 | Protein A |
性状 | Liquid |
缓冲液 | 0.2 μm filtered solution in PBS |
研究背景 | CD22 is a member of the immunoglobulin superfamily, SIGLEC family of lectins. It is first expressed in the cytoplasm of pro-B and pre-B cells, and on the surface as B cells mature to become IgD+. CD22 serves as an adhesion receptor for sialic acid-bearing ligands expressed on erythrocytes and all leukocyte classes. In addition to its potential role as a mediator of intercellular interactions, signal transduction through CD22 can activate B cells and modulate antigen receptor signaling in vitro. The phenotype of CD22-deficient mice suggests that CD22 is primarily involved in the generation of mature B cells within the bone marrow, blood, and marginal zones of lymphoid tissues. CD22 recruits the tyrosine phosphatase Src homology 2 domain-containing phosphatase 1 (SHP-1) to immunoreceptor tyrosine-based inhibitory motifs (ITIMs) and inhibits B-cell receptor (BCR)-induced Ca2+ signaling on normal B cells. CD22 interacts specifically with ligands carrying alpha2-6-linked sialic acids. As an inhibitory coreceptor of the B-cell receptor (BCR), CD22 plays a critical role in establishing signalling thresholds for B-cell activation. Like other coreceptors, the ability of CD22 to modulate B-cell signalling is critically dependent upon its proximity to the BCR, and this in turn is governed by the binding of its extracellular domain to alpha2,6-linked sialic acid ligands. However, genetic studies in mice reveal that some CD22 functions are regulated by ligand binding, whereas other functions are ligand-independent and may only require expression of an intact CD22 cytoplasmic domain at the B-cell surface. CD19 regulates CD22 phosphorylation by augmenting Lyn kinase activity, while CD22 inhibits CD19 phosphorylation via SHP-1.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy |
偶联 | Unconjugated |
免疫原 | Recombinant Mouse CD22 Protein (TMPY-04083) |
抗原种属 | Mouse |
研究领域 | Cancer Drug Targets, ITIM/ITAM Immunoreceptors and Related Molecules |
储存方式 | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
运输方式 | Shipping with blue ice. |
评论内容